System and method related to augmenting an immune system

• US 20080004849A1
• Filed: 08/13/2007
• Published: 01/03/2008
• Est. Priority Date: 08/24/2004
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Myhrvold, Nathan, Ishikawa, Muriel, Jung, Edward, Wilson, Richa, Wood, Lowell
• Application Number:
  US11/891,871
• Publication Number:
  US 20080004849A1
• Time in Patent Office: Days
• US Class Current: 703/11
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: C07K 16/00 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/0002
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present application relates, in general, to a system and/or method for detection and/or treatment.

Claims

1. A method, comprising:

identifying an association of at least a portion of one or more agents with at least a part of an immune response;

projecting a pattern of changes relating to the at least a portion of the one or more agents; and

selecting one or more immune response components in response to the projecting.

2. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting at least a part of one or more of a macrophage, a lymphocyte, an immune response modulator, an antigen receptor, or an antigen presenting cell.

3. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more modulators of at least a part of at least one of a macrophage, a lymphocyte, an immune response modulator, an antigen receptor, or an antigen presenting cell.

4. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more of modulators of at least a part of a B lymphocyte.

6. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting at least a part of one or more of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.

7. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more of a modulator of at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.

8. The method of claim 1, wherein the identifying an association of at least a portion of one or more agents with a part of an immune response further comprises:

identifying an association of at least a portion of at least one of a virus, a bacterium, a yeast, a mold, a fungus, a mycoplasma, a ureaplasma, a Chlamydia, a rickettsia, a nanobacterium, a prion, an agent responsible for TSE, a multicellular parasite, a protein,

5. (canceled)

9. (canceled)

10. (canceled)

11. (canceled)

12. (canceled)

13. (canceled)

14. (canceled)

15. (canceled)

16. (canceled)

17. (canceled)

18. (canceled)

19. A method, comprising:

projecting a pattern of changes relating to the at least a portion of one or more agents; and

selecting one or more immune response components in response to said projecting.

20. (canceled)